Viva Vision Biotech

Wenzhou, China · Founded 2016 · In IPO Registration

Developer and manufacturer of innovative ophthalmology therapeutics and ophthalmic formulations designed for anterior and posterior segment eye diseases. Viva Vision Biotech is based in Wenzhou, China and was founded in 2016. Its last reported valuation was $257 million in Nov 2025. It has raised $107 million.

Last reported valuation

$256.6M

Oct 2026

Priced at

—

Total raised

$107.4M

Last round

—

How much has Viva Vision Biotech raised?

$107.4Macross 0 recorded rounds

Free account

More of Viva Vision Biotech with a free account

·The complete investor list: 26 names
·Watch Viva Vision Biotech: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Viva Vision Biotech investors

26 investors are on record for Viva Vision Biotech, including HSG (Hong Kong), Guangdong Technology Financial Group, Lapam Capital and V-Capital.

For fundraisers

Raising for a company like Viva Vision Biotech?

26 investors have backed Viva Vision Biotech.

See all 26 investors →

Frequently asked about Viva Vision Biotech

How much has Viva Vision Biotech raised?: Viva Vision Biotech has raised $107.4M in total across 0 recorded funding rounds.